English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Three recombinant antigens  viz . arginine kinase, cathepsin L-1 and TES-26 of  Toxocara canis  were expressed in  Escherichia coli  and evaluated for their potential in the detection of  T .  canis  larval infection in human in immunoglobulin G-enzyme linked immunosorbent assay (IgG-ELISA). Results of the IgG-ELISA with the above recombinant antigens were confirmed with commercially available IgG detection kit for  T .  canis  infection used as a standard test. All three recombinant antigens were 100% sensitive in the detection of positive cases (n = 6) of  T .  canis  infection in human and were screened for their cross-reactivity in human patients with history of  Toxoplasma gondii ,  Plasmodium vivax ,  Entamoeba histolytica , hydatid and hookworm infections. The recombinant TES-26 antigen showed higher specificity and cross-reacted with  T .  gondii  infection sera only. However, arginine kinase and cathepsin L-1 recombinant antigens showed cross-reactions with sera of patients infected with  T .  gondii ,  P .  vivax  and  E .  histolytica  but not with the patient sera infected with hydatid and hookworm. These results show that recombinant TES-26 is a potential diagnostic candidate antigen for human toxocarosis caused by migrating  T .  canis  larvae.

Sero-detection of Toxocara canis infection in human with T . canis recombinant arginine kinase, cathepsin L-1 and TES-26 antigens